Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories™
- 10 July 2002
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 268 (2) , 131-140
- https://doi.org/10.1016/s0022-1759(02)00189-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic CellsThe Journal of Experimental Medicine, 2002
- Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DCCytotherapy, 2001
- Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapyProceedings of the National Academy of Sciences, 2001
- A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injectionInternational Journal of Cancer, 2001
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cellsNature Medicine, 1998
- Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditionsEuropean Journal of Immunology, 1997
- Improved methods for the generation of dendritic cells from nonproliferating progenitors in human bloodJournal of Immunological Methods, 1996
- Generation of mature dendritic cells from human blood An improved method with special regard to clinical applicabilityJournal of Immunological Methods, 1996
- Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cellsNature Medicine, 1996
- High gradient magnetic cell separation with MACSCytometry, 1990